| Product Code: ETC7625824 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Cardiovascular Genetic Testing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Cardiovascular Genetic Testing Market - Industry Life Cycle |
3.4 Ireland Cardiovascular Genetic Testing Market - Porter's Five Forces |
3.5 Ireland Cardiovascular Genetic Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.6 Ireland Cardiovascular Genetic Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Ireland Cardiovascular Genetic Testing Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.8 Ireland Cardiovascular Genetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Cardiovascular Genetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Ireland |
4.2.2 Growing awareness about personalized medicine and genetic testing |
4.2.3 Technological advancements in genetic testing leading to more accurate and affordable tests |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for genetic testing in Ireland |
4.3.2 Limited reimbursement policies for genetic testing services |
4.3.3 Concerns regarding privacy and data security in genetic testing |
5 Ireland Cardiovascular Genetic Testing Market Trends |
6 Ireland Cardiovascular Genetic Testing Market, By Types |
6.1 Ireland Cardiovascular Genetic Testing Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Inherited Cardiomyopathies, 2021- 2031F |
6.1.4 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Hypertrophic Cardiomyopathy (HCM), 2021- 2031F |
6.1.5 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Dilated Cardiomyopathy (DCM), 2021- 2031F |
6.1.6 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Arrhythmia, 2021- 2031F |
6.1.7 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Aortopathies, 2021- 2031F |
6.1.8 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Cardiovascular Genetic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Cytogenetic Testing, 2021- 2031F |
6.2.3 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Biochemical Testing, 2021- 2031F |
6.2.4 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Molecular Testing, 2021- 2031F |
6.3 Ireland Cardiovascular Genetic Testing Market, By Testing Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Predictive Testing, 2021- 2031F |
6.3.3 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Carrier Testing, 2021- 2031F |
6.3.4 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Prenatal and Newborn Testing, 2021- 2031F |
6.3.5 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Diagnostic Testing, 2021- 2031F |
6.3.6 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Pharmacogenomic Testing, 2021- 2031F |
6.3.7 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Cardiovascular Genetic Testing Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Chromosome Analysis, 2021- 2031F |
6.4.3 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Genetic Disease Diagnosis, 2021- 2031F |
6.4.4 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Cardiovascular Disease Diagnosis, 2021- 2031F |
6.4.5 Ireland Cardiovascular Genetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Cardiovascular Genetic Testing Market Import-Export Trade Statistics |
7.1 Ireland Cardiovascular Genetic Testing Market Export to Major Countries |
7.2 Ireland Cardiovascular Genetic Testing Market Imports from Major Countries |
8 Ireland Cardiovascular Genetic Testing Market Key Performance Indicators |
8.1 Average turnaround time for cardiovascular genetic testing |
8.2 Rate of adoption of genetic testing by healthcare providers in Ireland |
8.3 Number of research studies and clinical trials utilizing cardiovascular genetic testing |
9 Ireland Cardiovascular Genetic Testing Market - Opportunity Assessment |
9.1 Ireland Cardiovascular Genetic Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.2 Ireland Cardiovascular Genetic Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Ireland Cardiovascular Genetic Testing Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.4 Ireland Cardiovascular Genetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Cardiovascular Genetic Testing Market - Competitive Landscape |
10.1 Ireland Cardiovascular Genetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Ireland Cardiovascular Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here